{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:57:24Z","timestamp":1763765844552,"version":"3.37.3"},"reference-count":18,"publisher":"Wiley","issue":"S7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2162,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Cardiol"],"DOI":"10.1002\/clc.4960131403","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T12:02:39Z","timestamp":1278504159000},"page":"VII-6-VII-12","source":"Crossref","is-referenced-by-count":4,"special_numbering":"supplement S7","title":["Quinapril: Overview of preclinical data"],"prefix":"10.1002","volume":"13","author":[{"given":"Harvey R.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,30]]},"reference":[{"issue":"4","key":"10.1002\/clc.4960131403-BIB1|cit1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/000331978904000403","article-title":"Quinapril: A preclinical review of the pharmacology, pharmacokinetics, and toxicology","volume":"40","author":"Kaplan","year":"1989","journal-title":"Angiology"},{"key":"10.1002\/clc.4960131403-BIB2|cit2","first-page":"1326","article-title":"CI-906 and CI-907: New orally active nonsulfhydryl angiotensin-converting enzyme inhibitors","volume":"43","author":"Kaplan","year":"1984","journal-title":"Fed Proc"},{"issue":"4","key":"10.1002\/clc.4960131403-BIB3|cit3","article-title":"The clinical pharmacokinetics of quinapril","volume":"40","author":"Olson","year":"1989","journal-title":"Angiology"},{"key":"10.1002\/clc.4960131403-BIB4|cit4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-3565(25)24977-1","article-title":"Inhibition of angiotensin converting enzyme with quinapril (CI-906): Investigation of anti-hypertensive mechanisms in spontaneously hypertensive rats","volume":"234","author":"S\u00e4yn\u00e4v\u00e4lammi","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/clc.4960131403-BIB5|cit5","unstructured":"Ryan MJ Olszewski BJ Antihypertensive activity of quinapril given for 14 days to conscious spontaneously hypertensive rats. Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company"},{"key":"10.1002\/clc.4960131403-BIB6|cit6","first-page":"543","article-title":"Effects of two structurally different angiotensin converting enzyme inhibitors, captopril and quinapril (CI-906) in rats with one-kidney deoxycorticosterone-salt hypertension","volume":"8","author":"Portsti","year":"1986","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1002\/clc.4960131403-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0735-1097(88)92615-0","article-title":"Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope","volume":"12","author":"Packer","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1002\/clc.4960131403-BIB8|cit8","first-page":"S11","article-title":"Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors","volume":"7","author":"Johnston","year":"1989","journal-title":"J Hypertens"},{"key":"10.1002\/clc.4960131403-BIB9|cit9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1440-1681.1989.tb01563.x","article-title":"Angiotensin converting enzyme in the rat heart: Studies of its inhibition in vitro and ex vivo","volume":"16","author":"Fabris","year":"1989","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1002\/clc.4960131403-BIB10|cit10","doi-asserted-by":"crossref","unstructured":"Haleen SJ Weishaar RE Bousley RF Taylor DG The effects of quinapril, a new angiotensin converting enzyme (ACE) inhibitor, on the temporal progression of left ventricular failure in the cardiomyopathic hamster (abstr) Am J Hypertens 1990","DOI":"10.1161\/01.RES.68.5.1302"},{"issue":"2A","key":"10.1002\/clc.4960131403-BIB11|cit11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(86)90159-2","article-title":"Antihypertensive treatment and plasma lipoprotein levels: The associations in data from a population study","volume":"80","author":"MacMahon","year":"1986","journal-title":"Am J Med"},{"key":"10.1002\/clc.4960131403-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.1987.03400130082038","article-title":"Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension: Results from the Primary Prevention Trial in G\u00f6teborg, Sweden","volume":"258","author":"Samuelsson","year":"1987","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960131403-BIB13|cit13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2125.1988.tb03409.x","article-title":"Quinapril and blood lipids","volume":"26","author":"Koskinen","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/clc.4960131403-BIB14|cit14","first-page":"181","article-title":"Chronic toxicity evaluation of the nonsulfhydryl angiotensin converting enzyme inhibitor quinapril (abstr 729)","volume":"6","author":"Andrews","year":"1986","journal-title":"Toxicologist"},{"key":"10.1002\/clc.4960131403-BIB15|cit15","first-page":"733","article-title":"Preclinical toxicological evaluation of an angiotensin II converting enzyme inhibitor of the tetrahydro-quinoline series (abstr 2623)","volume":"43","author":"Anderson","year":"1984","journal-title":"Fed Proc"},{"key":"10.1002\/clc.4960131403-BIB16|cit16","unstructured":"E. R. Squibb & Sons. 1981"},{"key":"10.1002\/clc.4960131403-BIB17|cit17","unstructured":"Merck, Sharpe & Dohme Research Laboratories. Generic name: Enalapril maleate 1983"},{"key":"10.1002\/clc.4960131403-BIB18|cit18","unstructured":"Merck, Sharpe & Dohme Research Laboratories. Generic name: Lisinopril 1986"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960131403","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/clc.4960131403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T18:56:10Z","timestamp":1740250570000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960131403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,30]]},"references-count":18,"journal-issue":{"issue":"S7"},"URL":"https:\/\/doi.org\/10.1002\/clc.4960131403","relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"type":"print","value":"0160-9289"},{"type":"electronic","value":"1932-8737"}],"subject":[],"published":{"date-parts":[[2009,9,30]]}}}